Detects antibodies against myelin oligodendrocyte glycoprotein, commonly reported as MOG-IgG.
Used to support the diagnosis of MOG antibody-associated disease in people with compatible neurological conditions such as optic neuritis, transverse myelitis or acute disseminated encephalomyelitis. It is not intended for general screening.